Deepak NitriteQ1 FY27
Deepak Nitrite Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹1,754P/E: 30.1Market Cap: ₹23.8K CrSector: Chemicals & Petrochemicals
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- →Strong start to FY27 with record quarterly revenue of INR 2,592 crore, a 35% YoY and 22% QoQ growth.
- →Increasing volumes supported by improved demand across key end-user industries and new product introductions.
- →Capacity expansion in phenol plant targeting a run rate of 4 lakh tonnes annually; aiming to reach 1 lakh tonnes quarterly phenol production.
- →Ongoing commissioning of MIBK, MIBC, acetophenone projects to broaden product basket and support margin expansion.
- →Focus on value-added products in Advanced Intermediates with improved margins expected.
- →Continued ramp-up of recently commissioned assets and expected higher asset utilization.
- →Domestic business remains resilient with 85% revenue, exports growing steadily.
- →Optimistic medium to long-term outlook driven by diversification, backward integration, and new downstream product offerings.
- →Debottlenecking efforts and stable raw material procurements to support volume growth.
Margin guidance
Category 3- →Deepak Nitrite records highest-ever quarterly Revenue, EBITDA, PBT, and PAT in Q1 FY27, indicating strong growth momentum.
- →EBITDA margin expanded to 21%, supported by higher operating leverage, integration benefits, and cost efficiencies.
- →Ongoing capex (~INR 3,500 crore this year) in integrated projects like phenolics expansion, MIBK, MIBC, acetophenone, and polycarbonate expected to support sustainable earnings growth.
- →Strategic investments in backward integration (e.g., ammonia-to-amines chain) enhancing cost competitiveness and value addition.
- →Continued focus on high-value, integrated specialty chemicals and value-added product portfolios to drive margin expansion.
- →Operating environment improving with stronger demand outlook and diversified product and geographic presence reduces risks.
- →Management confident in sustaining profit growth with disciplined capital allocation and execution of growth projects.
- →Improving earnings quality and scalability of integrated business model expected to drive superior long-term operating earnings and EPS growth.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →For the ongoing INR 11,500 crore capex on propylene and polycarbonate projects, the funding is planned with a 60:40 debt-to-equity ratio.
- →Debt funding has already been tied up at very competitive rates and terms, ensuring no funding concerns.
- →Approximately INR 6,800 crore of debt (plus working capital) is currently borrowed, expected to peak around INR 8,000-8,500 crore by FY29, with a debt-to-equity ratio not crossing 1.
- →Around INR 1,200 crore has been spent, with INR 1,500 crore to 1,600 crore planned for the current year.
- →Equity contribution of 25% has been made; the remaining funding will come from bank debt tranches.
- →The company maintains a prudent capital structure with comfortable leverage and significant financial flexibility for growth projects.
Order book
The transcript provided on pages 1 to 21 of the Q1 FY 2027 earnings call for Deepak Nitrite Limited does not specifically mention details regarding current or expected order book or pending orders. The focus is mainly on:
- Production capacities and volumes, especially for phenol (close to 1 lakh tonnes run rate) and specialty chemicals like acetophenone, MIBK, and MIBC.
- Progress on capex (~INR 3500 crore for the year) and commissioning of new plants.
- Raw material procurement strategies and supply chain adjustments.
- Market dynamics, product validations, and customer engagement cycles.
- Development of advanced intermediates, R&D efforts including flow chemistry and fluorination scale-up.
No explicit quantitative or qualitative order book or backlog information was disclosed in this transcript.
Capex plans
Yes- →Ongoing capex of approximately INR 3,500 crore planned for the current year focused on site development, construction, and setting up imported assets (Page 15).
- →Total capex spent till now (last year and this year combined) around INR 3,000 crore; additional INR 3,000 crore planned for 2027-28 (Page 15).
- →INR 11,500 crore capex for integrated propylene and polycarbonate project funded with 60:40 debt-to-equity ratio; debt funding already tied up at competitive rates (Page 7).
- →Approximately INR 1,200 crore already spent this year; pending capex of INR 1,000-1,500 crore this year (Page 14).
- →Investments include debottlenecking and capacity expansions in phenol plant (aiming for 4 lakh tonnes), commissioning of acetophenone facility, and commissioning hydrogenation and nitration facilities (Pages 9, 15, 19).
- →Focus on strategic projects such as advanced intermediates, MIBK and MIBC projects, and integrated polycarbonate project (Pages 7, 18).
- →Funding arrangements secured; debt-to-equity expected to stay below 1 even at peak.
How does Deepak Nitrite rank vs peers in Chemicals & Petrochemicals?
Pro feature1Deepak Nitrite
Rev 2Mar 3
See full Chemicals & Petrochemicals sector rankings
How does Deepak Nitrite rank in Chemicals & Petrochemicals?
Compare Deepak Nitrite against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.